GORE TAG Conformable Thoracic Endoprosthesis TGU343410Recalls & reported problems
W. L. Gore & Associates, Inc. · TAG THORACIC ENDO CONFORM 34mmX10cm 22Fr · Class 3 · Implant
All models of GORE TAG Conformable Thoracic Endoprosthesis (20)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 6
- Deaths reported
- 0
- Injuries reported
- 6
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 00733132617807), received between Sep 1, 2018 and Dec 2, 2022 — classified as 6 injuries.
The most frequently reported specific device problem is “Activation, Positioning or Separation Problem” (2 reports).
6 other recalls cover devices cleared under the same FDA submission (P040043); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Activation, Positioning or Separation Problem2
- Adverse Event Without Identified Device or Use Problem1
- Appropriate Device Problem Term/Code Not Available1
- Fracture1
- Insufficient Device Problem Information1
- Leak/Splash1
- Patient-Device Incompatibility1
Patient problems
- No Known Impact Or Consequence To Patient2
- Aneurysm1
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1
- Clinical Endoleak1
- Fistula1
- Ruptured Aneurysm1
- Unspecified Infection1
- Vascular Dissection1
Recent adverse event reports
The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.
InjuryDec 2, 2022Leak/Splash; Insufficient Device Problem Information; Insufficient Device Problem Information
ON (B)(6) 2018 THE PATIENT WAS IMPLANTED WITH CONFORMABLE GORE® TAG® THORACIC ENDOPROSTHESES. AS REPORTED, ON (B)(6) 2018, THE PATIENT PRESENTED WITH A POSSIBLE TYPE II OR TYPE III ENDOLEAK. AS REPORTED, THERE IS SOME CONCERN OVER ACCESS SITES ON THE PATIENT SO AN ANGIOGRAM IS BEING PLANNED IN ORDER TO DETERMINE THE TYPE OF LEAK AND BEST ACCESS AND DEVICE FOR USE IN TREATMENT. AS REPORTED, A REINTERVENTION WILL BE SCHEDULED BASED ON THE RESULTS.
Patient problems: Clinical Endoleak
MAUDE report 15909568 ↗InjuryJul 18, 2022Activation, Positioning or Separation Problem; Appropriate Device Problem Term/Code Not Available; Activation, Positioning or Separation Problem; Appropriate Device Problem Term/Code Not Available
ON (B)(6) 2017 A PATIENT UNDERWENT TREATMENT OF A THORACIC AORTIC ANEURYSM, 45MM, ZONE 0, WITH GORE® TAG® THORACIC BRANCH ENDOPROSTHESES. A GORE® DRYSEAL FLEX SHEATH WAS UTILIZED FOR ACCESS. THE PATIENT TOLERATED THE PROCEDURE. ON (B)(6) 2017 A DISTAL TYPE I ENDOLEAK WITH MAXIMUM ANEURYSM SAC DIMENSION 70 MM ASSOCIATED WITH A NON-COMMERCIALLY AVAILABLE AORTIC COMPONENT WAS DISCOVERED. ON (B)(6) 2017, THE ADDITIONAL PROCEDURE WAS DONE AND TWO CONFORMABLE GORE® TAG® THORACIC ENDOPROSTHESES AS A DISTAL EXTENSION TO THE AORTIC COMPONENT WERE PLACED. THE FOLLOW UP IMAGING DATED (B)(6) 2017, DETERMINED THAT THERE WAS NO PRESENCE OF ENDOLEAK, A NEW AORTIC DISSECTION OR RUPTURE. ON (B)(6) 2017, A RUPTURED AORTA WAS DETERMINED. IT WAS REPORTED BY SITE THAT THE EVENT WAS RELATED TO DEVICE AND ENDOVASCULAR PROCEDURE. ON (B)(6) 2017 THE PATIENT EXPIRED. ACCORDING TO THE PHYSICIAN, LIKELY INFECTION OF THE STENT GRAFT AND AORTA CAUSED THE AORTIC RUPTURE. THE PHYSICIAN DEFINITIVELY STATED THAT THE DEVICE WAS INFECTED, THAT IT HAD ERODED INTO THE ESOPHAGUS, AS DOCUMENTED BY VISUALIZATION OF THE STENT GRAFT DURING ESOPHAGOSCOPY. THEREFORE, THE AORTIC WALL WAS NO LONGER INTACT, AND THE PATIENT EXPIR
Patient problems: Fistula; Ruptured Aneurysm; Unspecified Infection
MAUDE report 15047971 ↗InjuryMay 11, 2022Activation, Positioning or Separation Problem; Activation, Positioning or Separation Problem
ON (B)(6) 2016 A PATIENT UNDERWENT A TREATMENT OF A THORACOABDOMINAL AORTIC ANEURYSM ZONE 3, WITH TWO CONFORMABLE GORE® TAG® THORACIC ENDOPROSTHESES. CHIMNEY TECHNIQUE WAS USED WITH BRANCH VESSEL TREATMENT OF THE CELIAC, SUPERIOR MESENTERIC AND RIGHT RENAL ARTERIES. THE BRAND OF STENTS USED IN THE BRANCH VESSELS IS UNKNOWN. THE MAXIMUM AORTIC DIAMETER IN THE TREATMENT ZONE WAS 68MM BY CTA. THE FOLLOW UP CTA SHOWED THAT ON (B)(6) 2016 THE MAXIMUM AORTIC DIAMETER IN THE TREATMENT ZONE WAS 60.1MM. FROM (B)(6) 2017 TILL (B)(B) 2018 THE MAXIMUM AORTIC DIAMETER IN THE TREATMENT ZONE INCREASED IN SIZE FROM 62MM TO 64MM. IT WAS REPORTED THAT ON (B)(6) 2022, THE FOLLOW UP CTA SHOWED THAT THE MAXIMUM AORTIC DIAMETER WAS 89MM. REPORTEDLY, ON (B)(6) 2022, A GUTTER TYPE III ENDOLEAK RELATED TO THE ¿SNORKEL¿ PROCEDURE OF THE SUPERIOR MESENTERIC ARTERY (SMA) WAS NOTICED. DUE TO THE INFORMATION PROVIDED, THE ENDOLEAK WAS ATTRIBUTED TO THE GORE® TAG® THORACIC ENDOPROSTHESES. THERE WAS A POOR SEAL ALONG THE STENT USED FOR THE SNORKEL. THE PHYSICIAN DID NOT NOTICE ANY COMPONENT DISCONNECTION OR TEAR/DISRUPTION IN THE GRAFT MATERIAL. ON (B)(6) 2022, THE PATIENT UNDERWENT THE COIL EMBOLIZATION PROCEDUR
Patient problems: Aneurysm; Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available
MAUDE report 14366568 ↗InjuryAug 5, 2020Patient-Device Incompatibility; Patient-Device Incompatibility
ON (B)(6) 2019, THIS PATIENT UNDERWENT ENDOVASCULAR TREATMENT OF A THORACIC AORTIC ANEURYSM USING CONFORMABLE GORE TAG THORACIC ENDOPROSTHESES. A TGU343410 WAS DEPLOYED PROXIMAL, AND A TGU404010 WAS THEN PLACED DISTALLY. THE OVERLAP OF THE DEVICES WAS GREATER THAN 3 CM. ON (B)(6) 2019, 5-MONTH FOLLOW-UP CTA SCAN SHOWED A TYPE II ENDOLEAK WITH FILLING OF THE INTERCOSTALS ARTERIES. THE ANEURYSM INCREASED IN SIZE FROM 66 MM AT BASELINE TO 68 MM. THE PHYSICIAN OPTED TO REPEAT A CTA IN A YEAR. ON (B)(6) 2020, THE MORE RECENT CTA SHOWED CONTINUED GROWTH TO 76 MM. THERE ALSO APPEARED TO BE A TYPE III ENDOLEAK ON THE INNER CURVE OF THE TWO DEVICES. THERE APPEARED TO BE SOME ¿BIRD BEAKING¿ OF THE TGU404010 DEVICE. THIS WAS CONFIRMED WITH AN ANGIOGRAM ON (B)(6) 2020, AND THE ENTIRE STENTED SEGMENT WAS RELINED USING A SINGLE TGMR404015 DEVICE. FINAL ANGIOGRAMS SHOWED COMPLETE RESOLUTION OF THE ENDOLEAK.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 10368662 ↗InjuryAug 3, 2020Fracture; Fracture
THE FOLLOWING WAS REPORTED TO GORE: ON (B)(6) 2015, THIS PATIENT UNDERWENT ENDOVASCULAR TREATMENT OF AN THORACIC AORTIC ANEURYSM USING A CONFORMABLE GORE TAG THORACIC ENDOPROSTHESIS. FOLLOW UP SHOWED WHAT APPEARED TO BE A "FRACTURED OR DISCONNECTED" GORE TAG DEVICE. ON (B)(6) 2020, A REINTERVENTION OCCURRED WHEREBY THE DEVICE WAS RELINED. ADDITIONAL INFORMATION HAS BEEN REQUESTED.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 10359293 ↗InjurySep 1, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ON (B)(6) 2018, THE PATIENT WAS IMPLANTED WITH CONFORMABLE GORE® TAG® THORACIC ENDOPROSTHESES TO TREAT A NEW CHRONIC THORACIC AORTIC DISSECTION PROXIMAL TO THE EXISTING IMPLANTED DEVICES, NOT IN THE PREVIOUSLY TREATED AREA OF THE AORTA. PRIOR TO THIS PROCEDURE ON (B)(6) 2012, THE PATIENT WAS IMPLANTED WITH THREE GORE® TAG® THORACIC ENDOPROSTHESES TO TREAT A CHRONIC DISSECTION. ON (B)(6) 2017, THE PATIENT WAS IMPLANTED WITH GORE® EXCLUDER® AAA ENDOPROSTHESES IN THE ABDOMINAL AORTA, GORE® VIABAHN® ENDOPROSTHESES WERE IMPLANTED IN BILATERAL RENAL ARTERIES, THE CELIAC ARTERY AND SUPERIOR MESENTERIC ARTERY AS ¿CHIMNEYS¿ TO TREAT A NEW CHRONIC DISSECTION. IN ADDITION, ON AN UNKNOWN DATE, THE PATIENT HAD BARE METAL STENTS IMPLANTED IN BOTH FEMORAL ARTERIES. IT WAS REPORTED ACCESS WAS MADE THROUGH THE RIGHT FEMORAL ARTERY AND THAT AFTER DEPLOYING THE CONFORMABLE GORE® TAG® THORACIC ENDOPROSTHESIS (TGU343410/18359270) ON (B)(6) 2018, THE PROXIMAL END OF THE DEVICE PARTIALLY OPENED, APPROXIMATELY 30% OPEN, DOWN TO THE FIRST 1 CM OF THE DEVICE. THE REST OF THE DEVICE FULLY OPENED. THE PHYSICIAN ATTEMPTED TO BALLOON THE DEVICE AND IT REMAINED PARTIALLY OPEN. A GORE® EXCLUDER® CONTRALATERAL LEG
Patient problems: Vascular Dissection
MAUDE report 7840470 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P040043. One submission often covers many models, so check the product and lot details in each record.
- Z-0290-2021 · Sep 9, 2020 · Open, ClassifiedGORE TAG CONFORMABLE Thoracic Stent Graft with ACTIVE CONTROL System
- Z-0291-2021 · Sep 9, 2020 · Open, ClassifiedGORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL System
- Z-2052-2020 · Dec 17, 2019 · TerminatedConformable Thoracic Stent Graft, Rx only, Sterile EO - Product Usage: This device is intended for endovascular repair of lesions of the descending thoracic aorta.
- Z-0048-2018 · Sep 25, 2017 · TerminatedGORE TAG, THORACIC ENDOPROSTHESIS, CONFORMABLE. The GORE TAG Thoracic Endoprosthesis is intended for endovascular repair of all lesions of the descending thoracic aorta.
- Z-1236-06 · Apr 28, 2006 · TerminatedGORE TAG THORACIC ENDOPROSTHESIS System, Endovascular Graft, Aortic Aneurysm Treatment, Catalogue Number TG3410, 34mm x 10cm
- Z-1237-06 · Apr 28, 2006 · TerminatedGORE TAG THORACIC ENDOPROSTHESIS System, Endovascular Graft, Aortic Aneurysm Treatment, Catalogue Number TG3415, 34mm x 15cm
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page